Publications Update

Publications Update # 130

The influence of anxiety, search updates in GYOEDU, knowledge graph, mini-cards for publications update, opportunistic salpingectomy cost-effectiveness, ASCO guidelines - neoadjuvant chemotherapy in ovarian cancer and the futility ofmagnesium replacement

Publications Update # 129

Very low-risk cervical cancer appropriate for MIS simple hysterectomy (video), LASH trial, Pembrolizumab + Lenvatinib in Clear Cell Recurrences, cost-effective ways for genetic testing in ovarian cancer, PARP (olaparib) dose reductions and GYOEDU reminders

Publications Update # 128

How to form and break habits, MMR deficiency, MLH1 promoter hypermethylation, and outcomes, low-grade serous ovarian cancer 3026 trial, and FOLR1 expression in low-grade serous ovarian cancer. Updated video of neuroendocrine tumors.

Publications Update # 127

PORTEC 4A video summary and study summary, management of cancer in pregnancy, Mirvetuximab and occular side effects in real world setting and GYOEDU Launchpad details

Publications Update # 126

Kintsugi, the art of joining pottery, gyoedu search function update, mock oral dates released, KELIM score to decide who gets HIPEC, Compass study - nab-paclitaxel vs paclitaxel in platinum resisant ovarian cancer, ROSELLA trial Quiz, FZOCUS study

Publications Update # 125

Walk around the world, video tutorial - gastric type adenocarcinomas of the cervix, time to surgery - does it matter in ovarian cancer, pembrolizumab and lenvatinib in carcinosarcoma

Publications Update # 124

John Green's NYT interview, practical tips on how to integrate exercise in cancer treatment, dual PD-1 and CTLA-4 inhibition in MMRd/MSI cancers, video tutorial on cardiac toxicity of Immune Checkpoint inhibitors

Publications Update # 123

Joy/HBR; Sutures, needles & knots; Radiation shielding in pregnancy; MIS in UPSC; GYOEDU non-sloppy MIS guide; GYN residency proposal; Surgical leadership; Elite tennis training for surgeons.

Publications Update # 122

The case AI is thinking, Hormone Replacement Therapy - Part 1 video, Opportunistic Salpinectomy related articles, and the tug-of-war between the FDA and PARP inhibitor trial authors

Publications Update # 121

How to write a cover letter, HRD in endometrial cancer, GLP-1 agonists and the risk of cancer, revisiting intra-peritoneal chemotherapy